Global Generic Drugs Business Analysis Report 2023-2030: Small-molecule Generic Drugs Account for a Lion's Share, Biosimilars Exhibit Fastest Growth

News provided by

Oct 23, 2023, 14:45 ET

DUBLIN, Oct. 23, 2023 /PRNewswire/ -- The "Generic Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Global Generic Drugs Market to Reach $671.5 Billion by 2030

The global market for Generic Drugs estimated at US$403.9 Billion in the year 2022, is projected to reach a revised size of US$671.5 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2022-2030.

Small-Molecule Generics, one of the segments analyzed in the report, is projected to record 4.8% CAGR and reach US$538.8 Billion by the end of the analysis period. Growth in the Biosimilars segment is estimated at 19.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $122.8 Billion, While China is Forecast to Grow at 8.2% CAGR

The Generic Drugs market in the U.S. is estimated at US$122.8 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$126.8 Billion by the year 2030 trailing a CAGR of 8.2% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.8% and 5.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.

What`s New?

Special discussions on the global economic climate and market sentiment
Coverage on global competitiveness and key competitor percentage market shares
Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and trademarked research platform
Complimentary updates for one year
Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes

MARKET OVERVIEW

Impact of Covid-19 and Global Economic Update
COVID-19 Impact on Global Pharmaceutical Supply Chain and Generic Drugs Market
Demand for Generic Pain Killers Rises
A Prelude to Generic Drugs
Generic Drugs Market Set for a Rapid Growth
North America and Europe Dominate, Asia-Pacific to Exhibit the Fastest Growth
India- A Significant Market
Small-molecule Generic Drugs Account for a Lion's Share, Biosimilars Exhibit Fastest Growth
Exciting Times for Biosimilars
Competition
Generic Drugs - Global Key Competitors Percentage Market Share in 2023 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)
Market Opportunities
Strategies to Sustain Success
The Future of Generics & Biosimilars Look Bright amid Persistent Barriers
Market Challenges
Factors Affecting Prices & Accessibility
Recent Market Activity
BRANDS

MARKET TRENDS & DRIVERS

Generic Drugs Enjoy Adrenaline Rush with Regulatory & Scientific Support
R&D & Innovation Push
Efforts to Eliminate Barriers to Generics Development
Regulatory & Scientific Collaboration as Key
FDA's Generic Drug User Free Program
Policy Support to Generic Drugs: Clearing Road to Affordable Access to Quality Medicines
Savings in Billions
Taking GDUFA to Next Level
Pushing Competition through ANDAs
Major Push to COVID-19 Drugs
Patent Expiries Set to Widen the Addressable Market for Generic Drugs
Patent Expiries of Select Drugs in 2020
Patent Expiries of Select Drugs in 2021
Patent Expiries of Select Drugs in 2022
Patent Expiries of Select Drugs in 2023
Patent Expiry of Select Major Drugs in the US: 2020-2023
Robust Demand for Pharmaceutical Drugs Drives Demand for Generic Drugs
Cost Containment Measures Put Focus on Generics
Small Molecule Generics Represent the Dominant Segment
Specialty Generic Drugs Gain Popularity
Specialty Generics - The Way to Success Amid Challenges
Factors that can Provide Competitive Edge
Increasing Demand for Biosimilars, Driven by Patent Expiry of Major Biopharmaceutical Drugs
Patent Expiries of Major Biopharmaceutical Drugs in the US and Europe in the Recent Past
Progressive Regulatory Framework Accelerates Product Approvals & Subsequently Market Revenues
Specific Guidelines for Biosimilars in Various Countries with Year of Publication
Biosimilars Regulatory Agencies in Select Regional Markets
Biosimilar Approvals in the US (as of 2023)
Biosimilar Approvals in Europe (as of 2023)
Rising Healthcare Costs Drive Demand for Generic Drugs
World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Aging Population to Propel the Demand for Generic Drugs
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Significant Increase in Number of Patients Suffering from Chronic Diseases Fuel Demand for Generic Medicines
Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Number of New Cancer Cases and Deaths (in Million) by Region for 2018
US Regulators Struggle to Keep Up with the Global Market
Increased Dependency on Non-US Manufacturers
Patient Trust and Traceability
Drug Supply Shortage Risks
Fixing a Broken System
Hospitals Teaming Up to Develop Own Generic Drugs to Combat Shortages and High Prices
Use of Artificial Intelligence and Machine Learning in Pharmaceutical Manufacturing Witnesses a Surge

FOCUS ON SELECT PLAYERS (Total 255 Featured)

Abbott Laboratories
Apotex Inc.
ASKA Pharmaceutical Co., Ltd.
Aspen Pharmacare Holdings Limited
AstraZeneca Plc
Baxter International Inc.
Dr. Reddy's Laboratories Limited`
Eli Lilly and Company
Endo International plc
F. Hoffmann-La Roche AG
Fresenius Kabi AG
GSK plc
H. Lundbeck A/S
Incepta Pharmaceuticals Ltd.
Lupin Ltd.
Novo Nordisk A/S
Sandoz International GmbH
Sanofi-Aventis U.S. LLC
STADA Arzneimittel AG
Sun Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd.
Viatris Inc.

For more information about this report visit https://www.researchandmarkets.com/r/uhwdsn

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets